A machine learning model developed by researchers at the Johns Hopkins Kimmel Cancer Center filters out the biological noise in liquid biopsy samples, helping clinicians better match therapies to their patients’ tumors. 

BUFFALO, NY- June 9, 2026 – A new research paper was recently published in Volume 17 of Genes & Cancer, titled “Active Beta-Catenin (ABC) promotes an invasive phenotype in pediatric osteosarcoma.”

Dr Josep Maria Ribera, head of the Acute Lymphoblastic Leukaemia laboratory at the Josep Carreras Leukaemia Research Institute, has been awarded the prestigious EHA Clinical Excellence Award 2026. This distinction recognises his outstanding scientific and clinical contributions to the clinical haematology, his leadership in the international blood cancer research community and his long-lasting commitment to training and mentoring the new generations of haematologists.

 A cancer researcher at the University of Houston is reporting what makes malignant soft tissue cancer grow in children, identifying key mechanisms and molecular targets to prevent tumor progression in patients in future therapies of the fatal rhabdomyosarcoma.

New Memorial Sloan Kettering Cancer Center (MSK) research shows the largely overlooked "tail" region of mRNAs helps ensure key regulatory proteins get folded correctly — a fundamentally new understanding of their role.

Three commercially available radiology AI systems have shown the potential to flag early signs of breast cancer up to 6 years before a diagnosis, according to a new study.

Chemical changes added to proteins after they are made are emerging as a powerful way to understand how cancers grow, spread, evade immunity, and resist treatment. 

Bladder cancer remains difficult to treat once it becomes advanced, recurrent, or resistant to conventional therapies.